Shabahang Shahrokh 4
4 · ADiTx Therapeutics, Inc. · Filed Aug 3, 2020
Insider Transaction Report
Form 4
Shabahang Shahrokh
DirectorCHIEF INNOVATION OFFICER
Transactions
- Exercise of In-Money
Common Stock
2020-07-24$11.25/sh+47,222$531,248→ 996,256 total - Exercise of In-Money
Series B Warrant
2020-07-24$11.25/sh−47,222$531,248→ 0 total(indirect: See Footnote)Exercise: $0.00From: 2020-07-02Exp: 2025-06-29→ Common Stock (47,222 underlying)
Footnotes (2)
- [F1]949,034 shares of common stock are owned beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee.
- [F2]Held beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee.